comprehensive -WSS

comprehensive

author：comprehensive 2025-10-02 22:58:52 - browse：62

Adobe

You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

The nonprofits rake in a strong first quarter

My colleague Tara Bannow and I are absolute suckers for reading hospital financial statements. A huge amount of those documents were released last week, and the numbers mirror what we’ve been seeing over the past several months: Not all hospitals are in dire straits, and in fact, many continue to do quite well.

Tara sifted through the data of 20 nonprofit systems, and all but four reported higher operating and net margins in the first three months of 2024, compared with the first three months of 2023.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

leisure time

WSS

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Eli Lilly to acquire Versanis in heated race for weight loss drugs

As AI regulations shape up, health tech startups beg for clarity

Does aspartame cause cancer? What new WHO guidance says

Obamacare plans could cover weight loss drugs

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

explore

comprehensive

The nonprofits rake in a strong first quarter

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Jerome Adams on the need for new antivirals for Covid

Federal judge rules Oregon’s tough new gun law is constitutional

DIEP, the 'gold standard' of breast reconstruction, is under threat

New study raises questions about niacin and heart health

Drug repurposing or repositioning? The language matters

Involuntary treatment for addiction doesn't work

The cancer drug shortage isn’t new — and neither are the solutions

Medicare Advantage enrollment hits roughly 33.4 million

In Memoriam: Notable people who died in 2023

Medicare Advantage enrollment grows 7.1% to 33.4 million people

hotspot

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Europe sees delivery challenges ahead on Alzheimer's therapies

Flagship Pioneering startup Sonata Therapeutics lays off 21

The new HIV moral panic

J&J expands global access to TB drug amid advocacy campaign

focus

leisure time

focus

hotspot